An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS.
The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing.

In 2021, the global Organs-on-chips market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Organs-on-chips status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Organs-on-chips development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Organs-on-chips Scope and Market Size
Organs-on-chips market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Organs-on-chips market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Others

Segment by Application
Physiological Model Development
Drug Discovery
Toxicology Research

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Emulate Inc
CN Bio
TissUse
Mimetas
Insphero
Ascendance Bio
Kirkstall
Hurel
Synvivo
Axosim
Nortis Bio